Sequoia China-Backed AI Startup Xtalpi To Partner With Pharma Giant Eli Lilly In $250 Million Novel Drug Deal

Shenzhen-based Xtalpi, an AI-powered drug discoverer, announced Tuesday it has partnered with U.S. pharmaceutical giant Eli Lilly in a deal worth up to $250 million to unearth potential medicines for an undisclosed disease.